Global Nuclear Medicine Diagnostic Equipment Supply, Demand and Key Producers, 2023-2029

Global Nuclear Medicine Diagnostic Equipment Supply, Demand and Key Producers, 2023-2029

The global Nuclear Medicine Diagnostic Equipment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.



Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.

Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .

This report studies the global Nuclear Medicine Diagnostic Equipment production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Diagnostic Equipment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Diagnostic Equipment that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Nuclear Medicine Diagnostic Equipment total production and demand, 2018-2029, (K Units)

Global Nuclear Medicine Diagnostic Equipment total production value, 2018-2029, (USD Million)

Global Nuclear Medicine Diagnostic Equipment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Nuclear Medicine Diagnostic Equipment consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Nuclear Medicine Diagnostic Equipment domestic production, consumption, key domestic manufacturers and share

Global Nuclear Medicine Diagnostic Equipment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Nuclear Medicine Diagnostic Equipment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Nuclear Medicine Diagnostic Equipment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Nuclear Medicine Diagnostic Equipment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Siemens Healthineers, Philips, Mediso Medical Imaging Systems, Digirad, Toshiba, Compañía Mexicana, SurgicEye and CMR Naviscan, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Medicine Diagnostic Equipment market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Nuclear Medicine Diagnostic Equipment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Nuclear Medicine Diagnostic Equipment Market, Segmentation by Type
SPECT
PET

Global Nuclear Medicine Diagnostic Equipment Market, Segmentation by Application
Tumor Imaging
Bone Marrow Imaging
Endocrine System Imaging
Urinary System Imaging
Others

Companies Profiled:
GE HealthCare
Siemens Healthineers
Philips
Mediso Medical Imaging Systems
Digirad
Toshiba
Compañía Mexicana
SurgicEye
CMR Naviscan
DDD-Diagnostic
Positron
TeraRecon
Neusoft Group
United Imaging
MinFound Medical
SinoUnion Healthcare
Top Grade Healthcare

Key Questions Answered

1. How big is the global Nuclear Medicine Diagnostic Equipment market?

2. What is the demand of the global Nuclear Medicine Diagnostic Equipment market?

3. What is the year over year growth of the global Nuclear Medicine Diagnostic Equipment market?

4. What is the production and production value of the global Nuclear Medicine Diagnostic Equipment market?

5. Who are the key producers in the global Nuclear Medicine Diagnostic Equipment market?

6. What are the growth factors driving the market demand?